SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 66675
  • 2
    Herr HW, Dotan Z, Donat SM, Bajorin DF. Defining optimal therapy for muscle invasive bladder cancer. J Urol 2007; 177: 43743
  • 3
    Stenzl A, Cowan NC, De Santis M et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011; 59: 100918
  • 4
    Ramani VA, Bromage SJ, Clarke NW. A contemporary standard for morbidity and outcome after radical cystectomy. BJU Int 2009; 104: 62832
  • 5
    Isbarn H, Jeldres C, Zini L et al. A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 2009; 182: 707
  • 6
    Donat SM, Shabsigh A, Savage C et al. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. Eur Urol 2009; 55: 17785
  • 7
    Hollenbeck BK, Miller DC, Taub DA et al. The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. J Urol 2006; 176: 13638
  • 8
    Fairey A, Chetner M, Metcalfe J et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J Urol 2008; 180: 12834; discussion 34
  • 9
    Boström PJ, Kossi J, Laato M, Nurmi M. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2009; 103: 1916
  • 10
    Porter MP, Gore JL, Wright JL. Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study. World J Urol 2011; 29: 737
  • 11
    Gregg JR, Cookson MS, Phillips S et al. Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol 2011; 185: 906
  • 12
    Goossens-Laan CA, Gooiker GA, van Gijn W et al. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 2011; 59: 77583
  • 13
    Hines RB, Chatla C, Bumpers HL et al. Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol 2009; 27: 433945
  • 14
    Megwalu II, Vlahiotis A, Radwan M, Piccirillo JF, Kibel AS. Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol 2008; 53: 5819
  • 15
    Fairey AS, Jacobsen NE, Chetner MP et al. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database. J Urol 2009; 182: 8592; discussion 3
  • 16
    Koppie TM, Serio AM, Vickers AJ et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008; 112: 238492
  • 17
    Stimson CJ, Chang SS, Barocas DA et al. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol 2010; 184: 1296300
  • 18
    Taylor JM, Feifer A, Savage CJ et al. Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU Int 2011; doi:10.1111/j.1464-410X.2011.10391.x. [Epub ahead of print]
  • 19
    Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM Classification of Malignant Tumours. West Sussex: UK Wiley-Blackwell, 2010
  • 20
    Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291: 24417
  • 21
    Saklad M. Grading of Patients for Surgical Procedures. Anesthesiology 1941; 2: 2814
  • 22
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 37383
  • 23
    Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 64955
  • 24
    May M, Fritsche HM, Gilfrich C et al. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder.]. Urologe A 2011; 50: 8219
  • 25
    Liberman D, Lughezzani G, Sun M et al. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology 2011; 77: 6606
  • 26
    Malavaud B, Vaessen C, Mouzin M, Rischmann P, Sarramon J, Schulman C. Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score. Eur Urol 2001; 39: 7984
  • 27
    Lund L, Jacobsen J, Clark P, Borre M, Norgaard M. Impact of comorbidity on survival of invasive bladder cancer patients, 1996–2007: a Danish population-based cohort study. Urology 2010; 75: 3938